Frantz Victor

504 total citations
15 papers, 400 citations indexed

About

Frantz Victor is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Frantz Victor has authored 15 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Frantz Victor's work include HIV/AIDS drug development and treatment (6 papers), Viral Infections and Immunology Research (4 papers) and Hepatitis C virus research (4 papers). Frantz Victor is often cited by papers focused on HIV/AIDS drug development and treatment (6 papers), Viral Infections and Immunology Research (4 papers) and Hepatitis C virus research (4 papers). Frantz Victor collaborates with scholars based in United States. Frantz Victor's co-authors include Wayne A. Spitzer, Joseph Tang, Mark J. Tebbe, Emma R. McKinney, Robert B. Johnson, Shu‐Hui Chen, John I. Glass, Beverly A. Heinz, Nathan Yumibe and Mark Wakulchik and has published in prestigious journals such as Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy and Tetrahedron Letters.

In The Last Decade

Frantz Victor

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frantz Victor United States	11	237	127	96	83	59	15	400
Bounkham Thavonekham Canada	13	207 0.9×	131 1.0×	96 1.0×	62 0.7×	53 0.9×	20	388
Shintaro Hirashima Japan	8	255 1.1×	76 0.6×	99 1.0×	142 1.7×	71 1.2×	8	428
Savina Malancona Italy	13	215 0.9×	122 1.0×	101 1.1×	107 1.3×	75 1.3×	21	413
Anja Johansson Sweden	7	180 0.8×	101 0.8×	82 0.9×	122 1.5×	40 0.7×	7	351
Avinash Phadke United States	11	175 0.7×	90 0.7×	45 0.5×	94 1.1×	76 1.3×	35	418
Keshab Sarma United States	12	182 0.8×	133 1.0×	124 1.3×	123 1.5×	98 1.7×	24	439
Kenny Simmen Belgium	7	121 0.5×	99 0.8×	99 1.0×	128 1.5×	96 1.6×	8	327
Cristina Gardelli Italy	14	287 1.2×	202 1.6×	239 2.5×	95 1.1×	84 1.4×	26	584
Yves Bousquet Canada	13	258 1.1×	195 1.5×	211 2.2×	220 2.7×	113 1.9×	15	575
Angelica Linton United States	8	134 0.6×	117 0.9×	116 1.2×	151 1.8×	86 1.5×	10	373

Countries citing papers authored by Frantz Victor

Since Specialization

Citations

This map shows the geographic impact of Frantz Victor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frantz Victor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frantz Victor more than expected).

Fields of papers citing papers by Frantz Victor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frantz Victor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frantz Victor. The network helps show where Frantz Victor may publish in the future.

Co-authorship network of co-authors of Frantz Victor

This figure shows the co-authorship network connecting the top 25 collaborators of Frantz Victor. A scholar is included among the top collaborators of Frantz Victor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frantz Victor. Frantz Victor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Zhang, Deyi, María‐Jesús Blanco, Bai‐Ping Ying, et al.. (2015). Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT1F receptor agonists: Evolution from bicyclic to monocyclic cores. Bioorganic & Medicinal Chemistry Letters. 25(19). 4337–4341. 5 indexed citations

Zhang, Deyi, David M. Bender, Frantz Victor, et al.. (2008). Facile rearrangement of N4-(α-aminoacyl)cytidines to N-(4-cytidinyl)amino acid amides. Tetrahedron Letters. 49(13). 2052–2055. 6 indexed citations

Chen, Shuhui, Frantz Victor, Robert B. Johnson, et al.. (2005). P1 and P1; Optimization of [3,4]-Bicycloproline P2 Incorporated Tetrapeptidyl α-Ketoamide Based HCV Protease Inhibitors. Letters in Drug Design & Discovery. 2(2). 118–123. 16 indexed citations

Victor, Frantz, Robert B. Johnson, John I. Glass, et al.. (2004). P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(19). 5007–5011. 30 indexed citations

Victor, Frantz, Nancy Snyder, Nathan Yumibe, et al.. (2003). P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 257–261. 26 indexed citations

Victor, Frantz, Robert B. Johnson, John I. Glass, et al.. (2003). Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 14(1). 251–256. 38 indexed citations

Chen, Shu‐Hui, Frantz Victor, Nancy Snyder, et al.. (2003). Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 13(20). 3531–3536. 16 indexed citations

Victor, Frantz, et al.. (2003). Novel P4 truncated tripeptidyl α-ketoamides as HCV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 263–266. 15 indexed citations

Victor, Frantz, et al.. (1998). ChemInform Abstract: Synthesis and Antiviral Activity of C2 Analogues of Enviroxime: An Exploration of the Role of Critical Functionality.. ChemInform. 29(3). 2 indexed citations

10.

Tebbe, Mark J., et al.. (1997). Antirhino/Enteroviral Vinylacetylene Benzimidazoles: A Study of Their Activity and Oral Plasma Levels in Mice. Journal of Medicinal Chemistry. 40(24). 3937–3946. 113 indexed citations

11.

Spitzer, Wayne A., Frantz Victor, B.A. Heinz, et al.. (1997). Antiviral activity, and biological properties of vinylacetylene analogs of enviroxime. Antiviral Research. 34(2). A87–A87. 1 indexed citations

12.

Victor, Frantz, Thomas J. Brown, Kristina Campanale, et al.. (1997). Synthesis, Antiviral Activity, and Biological Properties of Vinylacetylene Analogs of Enviroxime. Journal of Medicinal Chemistry. 40(10). 1511–1518. 39 indexed citations

13.

Victor, Frantz, Richard J. Loncharich, Joseph Tang, & Wayne A. Spitzer. (1997). Synthesis and Antiviral Activity of C2 Analogs of Enviroxime: An Exploration of the Role of Critical Functionality. Journal of Medicinal Chemistry. 40(21). 3478–3483. 18 indexed citations

14.

Colacino, Joseph M., Donald C. DeLong, James Nelson, et al.. (1990). Evaluation of the anti-influenza virus activities of 1,3,4-thiadiazol-2-ylcyanamide (LY217896) and its sodium salt. Antimicrobial Agents and Chemotherapy. 34(11). 2156–2163. 22 indexed citations

15.

Spitzer, Wayne A., et al.. (1988). Imidazo[1,2-a]pyrimidines and imidazo[1,2-a]pyrazines: the role of nitrogen position in inotropic activity. Journal of Medicinal Chemistry. 31(8). 1590–1595. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact